1
Luttjeboer, Jos, Simons, Joost, Westra, Tjalke, Wilschut, Jan, Boersma, Cornelis, Postma, Maarten, van der Schans, Jurjen
Veröffentlicht in: Luttjeboer , J , Simons , J , Westra , T , Wilschut , J , Boersma , C , Postma , M & van der Schans , J 2023 , ' An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands ' , Infectious diseases and therapy , vol. 12 , no. 8 , pp. 2135-2145 . https://doi.org/10.1007/s40121-023-00851-9;
2023
Veröffentlicht in: Luttjeboer , J , Simons , J , Westra , T , Wilschut , J , Boersma , C , Postma , M & van der Schans , J 2023 , ' An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands ' , Infectious diseases and therapy , vol. 12 , no. 8 , pp. 2135-2145 . https://doi.org/10.1007/s40121-023-00851-9;
2023
2
Luttjeboer, Jos, Setiawan, Didik, Cao, Qi, Daemen, Toos CAHH, Postma, Maarten J.
Veröffentlicht in: Luttjeboer , J , Setiawan , D , Cao , Q , Daemen , T CAHH & Postma , M J 2016 , ' Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands ' , Vaccine , vol. 34 , no. 50 , pp. 6381-6387 . https://doi.org/10.1016/j.vaccine.2016.10.019;
2016
Veröffentlicht in: Luttjeboer , J , Setiawan , D , Cao , Q , Daemen , T CAHH & Postma , M J 2016 , ' Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands ' , Vaccine , vol. 34 , no. 50 , pp. 6381-6387 . https://doi.org/10.1016/j.vaccine.2016.10.019;
2016
3
4
5
6
7
8
Postma, Maarten J.
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
9
10